Please log in to view this page
Username
Password
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
Purpose: The C-TRIUMPH study has identified 20 household contacts (HHC), who have progressed to active TB from its HHCs cohort...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
